112086-47-2 Usage
Chemical structure
derivative of phenylmethanamine
It is derived from phenylmethanamine, which is a compound containing a phenyl group attached to a nitrogen atom.
Presence of an imidazole ring
The compound contains an imidazole ring, which is a five-membered ring with two nitrogen atoms and three carbon atoms.
Pharmaceutical industry use
It is used in the development of drugs targeting imidazole receptors, which are involved in various physiological processes.
Potential applications
research related to imidazole derivatives
The compound may be used in research to study the effects of imidazole derivatives on biological systems.
Building block in organic synthesis
It can be used as a building block for the preparation of other imidazole-containing compounds.
Pharmacological and medicinal significance
Due to its structural properties and potential biological activities, the compound is considered to have pharmacological and medicinal importance.
Structural properties
The compound's structure, which includes the phenyl group, the imidazole ring, and the amine group, contributes to its potential pharmacological and medicinal significance.
Potential biological activities
The compound may exhibit biological activities due to its interaction with imidazole receptors and other biological targets.
Check Digit Verification of cas no
The CAS Registry Mumber 112086-47-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,0,8 and 6 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 112086-47:
(8*1)+(7*1)+(6*2)+(5*0)+(4*8)+(3*6)+(2*4)+(1*7)=92
92 % 10 = 2
So 112086-47-2 is a valid CAS Registry Number.
112086-47-2Relevant articles and documents
DEGRADABLE IMIDAZOLIUM OLIGOMER AND POLYMER FOR ANTIMICROBIAL APPLICATIONS
-
Page/Page column 36; 37, (2019/01/16)
The present invention relates to an imidazolium oligomer of formula (I) and an imidazolium oligomer or a polymer of formula (II) where the various groups are as defined in the specification. The present invention also relates to the methods for their preparation, antimicrobial composition, antimicrobial gel containing these oligomers and/or polymers of Formula (I) and (II), and uses of these oligomers and/or polymers in the treatment of a microbial infection or disease.